Legal News

Biotech IPO Freeze Continues As Second Quarter Is Slowest In More Than A Decade

Summer weather is heating up but the market for IPOs remains cold. Bausch + Lomb’s successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years. The post Biotech I

logo.png  By IG  Jul 6, 2022